Drug Device Combination Products Market, By Products (Drug Eluting Stents, Transdermal Patches, Infusion Pumps, Drug Eluting Balloon, Inhalers, and Other Products), By Application (Cardiovascular, Diabetes, Cancer Treatment, Respiratory Diseases, and Other Applications), By End User (Hospitals, Ambulatory Surgical Centre’s, and Other End User), and By Region (North America, Latin America, Europe, Asia-Pacific, Middle East and Africa)

Published In : Jul 2023

Code : CMI3919

Pages :278

Formats :

Excel and PDF

Industry : Medical Devices

Leading Companies

Global Drug Device Combination Product Market- Key Players

Major players operating in the global drug device combination product market include AbbVie Inc. (Allergan), Terumo Corporation, GlaxoSmithKline PLC, Novartis AG, Medtronic PLC, Abbott Laboratories, Boston Scientific Corp., W L Gore and Associates Inc., Stryker Corporation, and Becton, Dickinson and Company,

Global Drug Device Combination Product Market: Key Developments

On February 19, 2020, Flowonix Medical, Inc., received U.S. FDA approval to market the Prometra II Pump System for intrathecal baclofen delivery. This device offers expanded treatment options, with 20 mL and 40 mL capacities, and features a valve-gated mechanism for comprehensive spinal cord coverage. With a battery life of over 10 years, it reduces the need for pump replacements. This development provides new possibilities for managing severe spasticity in conditions, such as cerebral palsy and multiple sclerosis. Flowonix aims to establish the Prometra System as the gold standard in intrathecal baclofen therapy through collaborations with leading physicians.

On September 14, 2022, Terumo Cardiovascular Terumo manufactures the longest running line of commercially available heart-lung machines in the world, and is a leader in quality systems management. Terumo Cardiovascular opens a new manufacturing facility in Costa Rica, investing US$42 million to produce perfusion circuits for cardiovascular surgeries. The expansion supports global customers, improves patient care, and takes advantage of Costa Rica's stable economy and skilled workforce. The facility commenced operations in August 2022 and aims to employ around 300 associates by year-end.

On November 14, 2022, Stryker is one of the world's leading medical technology company. Stryker introduced the OR (operating room model) of the future, a model operating room in Flower Mound, Texas. It offers customers an interactive experience to explore advanced OR (operating room model) design and technology. The model prioritizes patient and staff safety, productivity, and operational efficiency, incorporating features for infection prevention, clean ability, and intelligent technology. It showcases seamlessly integrated software and equipment, sterility enhancements, and personalized patient care through continuous data generation. The design elements aim to save time and cost during construction and allow for future upgrades. Stryker aims to empower surgical teams and deliver high-performing ORs (operating room model) that enhance patient care.

On May 22, 2023, Becton, Dickinson and Company (BD), BD is one of the largest global medical technology companies in the world and is advancing the world of healthTM by improving medical discovery. BDannounced the worldwide commercial launch of the BD FACSDiscover S8 Cell Sorter, a new-to-world cell sorting instrument. It incorporates two breakthrough technologies, BD SpectralFX Technology and BD CellView Image Technology, which enable researchers to obtain more detailed information about cells that were previously invisible in traditional flow cytometry experiments.